Potential Anticancer Mechanisms of a Novel EGFR/DNA-Targeting Combi-Molecule (JDF12) against DU145 Prostate Cancer Cells: An iTRAQ-Based Proteomic Analysis

Figure 5

The expression level of some important proteins detected by iTRAQ. Qualification criteria for peptides were unused confidence score ≥ 1.3 and confidence level ≥ 95%. Average fold change ≥ 1.5 was classified as upregulated and average fold change ≤ 0.67 was defined as downregulated.